Presidio-sponsored SPAC Murphy Canyon to merge with Conduit Pharmaceuticals; CFO to join combined co.
Presidio Property Trust, Inc.
Definitive business combination agreement between Murphy Canyon Acquisition Corp. (sponsored by Presidio) and Conduit Pharmaceuticals; combined co. to list as CDT on Nasdaq.
Pro forma enterprise value ~$700.49M; up to $136.04M cash from Murphy trust; $27M PIPE investment anchored by new and existing Conduit investors.
Closing expected Q1 2023, subject to stockholder approvals; existing Conduit shareholders to own ~76.48% of pro forma combined co.
Presidio CFO Adam Sragovicz to resign upon closing and become CFO of the combined company.
Adam Sragovicz, the Chief Financial Officer of Presidio Property Trust, Inc. (the “Company”), is expected to resign from all positions with the Company upon the closing of the business combination transaction and join the combined company as its Chief Financial Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Adam Sragovicz departed as Chief Financial Officer at Presidio Property Trust, Inc..
Action
resign
Role
Chief Financial Officer
Exact text from the filing
Adam Sragovicz, the Chief Financial Officer of Presidio Property Trust, Inc. (the “Company”), is expected to resign from all positions with the Company upon the closing of the business combination transaction and join the combined company as its Chief Financial Officer.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.